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A B S T R A C T
Lactoferrin (Lf) is an iron-binding glycoprotein found in exocrine secretions including
milk. High levels of lactoferrin may have a role in the prevention of microbial infection of
the mammary gland. In this report we sequenced and characterized goat lactoferrin cDNA
and its promoter region in two different breeds of goat. The complete cDNA comprised
2356 nucleotides, including 38 bp at the 50-UTR and 194 bp at the 30-UTR. The open
reading frame is 2127 bp long and it encodes amature protein of 689 aminoacids. A total of
19 nucleotide differences, 11 of them being responsible for 8 aminoacid changes, were
identiﬁed through the comparison with French, Korean and Tibetan goat lactoferrin
cDNAs. About 1700 bp of the lactoferrin gene promoter were sequenced. Sequence
analysis revealed a non-canonical TATA box, multiple SP1/GC elements, and other putative
binding sites for transcription factors, such as NF-kB, STAT3 and AP2. Two SNPs were
identiﬁed, one ofwhichwould seem to create a new putative AP2 consensus sequence. The
presence of an additional AP2 binding site could be associated with quantitative
differences of such protein fraction, which could enhance all the activities related to such
protein, and improve mammary gland defence against bacterial infections.
 2009 Elsevier B.V. All rights reserved.
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journal homepage: www.e lsev ier .com/ locate /vet immLactoferrin is a bioactive iron-binding glycoprotein of
80-kDa which has been found in milk and other exocrine
secretions. Many functions have been attributed to
lactoferrin (for a review, Gonza´lez-Cha´vez et al., 2009),
however, its best known role is the primary defence
against microbial infection, mainly through iron seques-
tration required for microbial growth, direct interaction
with bacterial surface (Legrand et al., 2008) and direct
bactericidal activity due to lactoferricins (Bellamy et al.,
1992; van der Kraan et al., 2006).
The antimicrobial action of lactoferrin and its role in
the natural defence mechanism of the mammary gland
make it a candidate gene for increasing resistance against* Corresponding author. Tel.: +39 0812539004; fax: +39 0817762886.
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doi:10.1016/j.vetimm.2009.09.002bacterial infections in farm animals. In dairy cattle, its
concentration dramatically increases during the dry
period and a mastitis infection (Kutila et al., 2003),
suggesting that this protein plays important physiological
roles in the reduction of mastitis incidence (Hagiwara
et al., 2003). In the goat, the same concentration of
lactoferrin secreted from two different genetic types
showed different antibacterial activity. In particular,
Saanen goat lactoferrin exhibited no activity against
Escherichia coli O111, even at 7.5mg/ml, whereas Korean
native goat lactoferrin was already effective at 5mg/ml.
These observations suggested that the different antibac-
terial activities may be the result of differences in the
protein conformation caused by the polymorphisms in
the goat lactoferrin gene (Lee et al., 1997). This gene
has been mapped on chromosome 22; its main feature
is the extremely split architecture consisting in 17 exons
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protein have received adequate attention, the molecular
mechanisms of gene expression and regulation remain
relatively unknown.
Studying mastitis incidence in Southern Italy goat
breeds, we noticed that its occurrence in Nicastrese goat
was lower compared to the other breeds as, for example,
Saanen goat (unpublished data). Our interest in these data
prompted us to speculate that lactoferrin could play amore
active role in mammary gland innate defence mechanisms
against infections. Aim of this work was, therefore, to
characterize the lactoferrin cDNA, the regulatory regions of
gene promoter in the Italian Nicastrese and Saanen breeds
and to identify mutations which could potentially affect
milk lactoferrin concentration or produce aminoacid
changes.
Genomic DNA was isolated from leukocytes obtained
from individual blood samples, using conventional phe-
nol–chloroform extraction method. The DNA was then
resuspended in 100ml TE pH 7.6 (10mMTris, 1mMEDTA).
According to Chomczynsky and Sacchi (1987), total
RNAwas extracted frommilk somatic cells of ﬁve goats per
breed, at the end of the lactation stage. cDNA synthesis was
performed using Improm-IITM Reverse-Transcriptase (Pro-
mega) as follows: 1mg of total RNA was incubated with
10mM of the reverse primer LF17R: 50-AGGGAATGAAAAT-
CAACAGCA-30 in a volume of 10ml according to the
manufacturer’s guidelines conditions.
The whole cDNA and the promoter of the goat
lactoferrin gene were ampliﬁed using an iCycler-IQ (Bio-
Rad). Primers were designed by DNASIS-Pro (Hitachi)
using, as templates, the sequence of the goat lactoferrin
cDNA (EMBL Acc. No.: X78902) for the couple LF1F 50-
CGGAGTCGCCCCAGG-30 and LF17R (amplicon A) and the
sequence of the cattle lactoferrin gene and promoterTable 1
Comparison among the Italian goat LTF cDNA sequence and French, Korean na
A total of 19 nucleotide differences (bold letters) were detected, 11 of them are
correspond to the same coding triplets, asterisk shows unavailable sequence, das
does not determine remarkable difference in the estimated molecular weight o(EMBL Acc. No.: AY319306) for the following primers
LFPRF 50-TCCTTTTCATTGGCAAATGAG-30 and LF1R 50-
GGCGGGGACGAAGAG-30 (amplicon B); LF50F 50-AGATA-
CAAAGATGCTTCA-30 coupled with a primer designed
on newly determined goat promoter sequence LFPRR
50-TGGCAGAGGCAATAT-30 (amplicon C).
The PCR reaction mix (50ml) comprised: 100 ng of
genomic DNA or cDNA, 1 PCR Buffer (Promega), 2.5mM
MgCl2, 5 pmol of each primer, dNTPs each at 400mM, 2.5 U
of Taq DNA Polymerase (Promega). PCR conditions
included an initial cycle of denaturation at 95 8C for
4min followed by 35 cycles at 95 8C for 60 s, 58 8C
(amplicons A and B)–54 8C (amplicon C) for 45 s, 72 8C
for 90 s, and a ﬁnal extension at 72 8C for 10min. PCR
products were puriﬁed with QIAquick columns, inserted
into pDrive vector (Qiagen), and then used to transform
chemically QIAGEN EZ competent cell following the
manufacturers’ guidelines. Screening of the recombinant
clones was performed by PCR using the plasmid primers
M13. More than 10 clones of each PCR product were
sequenced on both strands by automated sequencer (ABI-
PRISM, Applied Biosystems) using standard cycle condi-
tions by Sanger’s dideoxy-chain termination method.
Comparison among sequences andmultiple alignments
were accomplished using DNASIS-Pro. The putative
regulatory motifs were searched by AliBaba 2.1 software.
The complete goat lactoferrin cDNA was sequenced for
the two investigated breeds. It comprised 2356 nt (EMBL
Acc. No. FM875929). Analysis of the sequence revealed one
ORF 2127 bp long (positions 39–2162), plus 38 and 194
nucleotides in the 50- and 30-UTR, respectively. The signal-
peptide (19 aminoacids) is encoded by the nucleotides 39–
95, the stop-codon (TAA) is realized between the nucleo-
tides 2163–2165, whereas the polyadenylation-signal is in
positions 2322–2327. No nucleotide differences weretive and Tibetan goat LTF cDNA.
responsible for 8 aminoacid changes (bold and italic letters). Grey cells
h indicate non-translated sequences. The different nucleotide combination
f the deduced mature protein (689 aminoacids).
Fig. 1. Alignment of deduced goat lactoferrin aminoacid sequence with other lactoferrin sequences deposited in GenBank. It is a polypeptide chain folded into
two symmetrical lobes (N lobe: aminoacids 1–332 and C lobe: aminoacid 344–689 of themature protein), connected by a hinge region containing ana-helix
(aminoacids333–343),whichprovidesﬂexibility to themolecule.Gapswere introducedin thesequences indicatedbydots (). Identityofaminoacids isdenoted
by hyphens (-). Full conserved aminoacids among the species are symbolized by asterisk (*). The signal peptide cleavage site is in italics. Bioactive peptides are
underlined. The potential N-glycosylation sites in goat lactoferrin are double-underlined. Percentage of identity, calculated by DNASIS, are in bold.
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comparison with the lactoferrin cDNA of French (EMBL
Acc. No.: X78902), Korean native (U53857) and the Tibetan
goat (DQ387456), showed 19 nucleotide differences
(respectively 9, 8 and 5), 11 of them being responsible
for 8 aminoacid changes. Consequently, the Italian goat
lactoferrin cDNA appears to be a new and particular allelic
combination, in fact, the ﬁrst part (ex1–ex8) appears to be
more similar to the Korean and Tibetan cDNAs, conversely
the second fraction (ex9–ex17) more homologue to the
French counterpart (Table 1).
By comparing the deduced lactoferrin aminoacid
sequence with the known Lf sequences available in
GenBank, we found that the degree of conservation among
species varies from 56.4% vs mouse to 97.7% vs sheep
(Fig. 1). The analysis of the primary structure of the goat
lactoferrin showed: (a) the signal-peptide, which is fully
conserved among the ruminants with a cleavage site at
positions 19 and 20 (LGLCLA#AP); and (b) the mature
protein (689 aminoacids). Other features include: (a) three
potential bioactive peptides: one lactoferricin (KLGAP-
SITCVRR),which is one of themain peptides responsible for
antibacterial properties of lactoferrin in cattle (Bellamy
et al., 1992) and appears to be strongly conserved among
ruminants; and two lactoferrampins (NLIWELLRKA-
QEKFGKNKSQ and WELLRKAQEKFGKNKSQ), which in
cattle show strong bactericidal activities against Gram-
positive and Gram-negative bacteria (van der Kraan et al.,
2006); (b) ﬁve potential glicosilation sites (Asn-X-Ser/Thr)
one of which (NQT) at the Asn495 residue is fully
conserved among the species (Fig. 1).In order to understand whether lactoferrin could affect
the different mastitis incidence between these two breeds
even in absence of polymorphisms in the coding regions,
we decided to extend the sequencing to the 50-ﬂanking
region and to analyze the putative regulatory regions.
About 1700 bp of the lactoferrin gene was ampliﬁed and
sequenced (EMBL Acc. No. AJ784283). The lactoferrin
promoter contains a non-canonic TATA-box located, with
reference to the ﬁrst nucleotide of the ﬁrst exon, at
nucleotides 28/24; at least three GC-boxes (1369/
1364, 948/934, 164/159) and two SP1 binding
sites (200/187, 69/55). The high GC content (64.9%)
is a typical feature of housekeeping genes promoters and
the presence of these last sites could contribute to the
constitutive expression of the lactoferrin in various tissues.
In particular, a non-canonic TATA-box (ATAAA) and a SP1
binding site at position 69/55 are almost perfectly
conserved in other 7 species (cattle, human, pig, mouse,
rat, camel and buffalo), suggesting that these two sites
might play a fundamental role in the regulation of
lactoferrin gene in vivo (Zheng et al., 2005). The region
spanning from nucleotides 1009 to 841 contains three
potential LPS-responsive elements: one STAT3 motif
(1009/991), and two NF-kB sites (960/949, 852/
838). STAT3 is known as a response factor to acute
inﬂammatory phases, whereas NF-kB plays a central role
in immunitary response and it can be activated by Toll-like
receptors (Muzio et al., 2000).
Compared to the Saanen conterpart, the promoter
sequence of the Nicastrese lactoferrin gene, is character-
ized by two SNPs: a transition A!G (nt 333) and a
Fig. 2. Schematic representation of the 50 regulatory region, of the exon 1
and polymorphisms detection in the goat lactoferrin gene. Dots represent
CpG islands of the promoter. The 50 untranslated region (UTR) of the exon
1 is shown as black box.
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86 (Fig. 2). The ﬁrst one, apparently does not interest any
known regulatory site, whereas the cytosine insertion
would create a new putative AP2 binding site (GCCTGGGG)
(Fig. 2), located 53 bp upstream the TATA-box, and
between two SP1 motifs. The estrogen receptor AP2 is
known to be an important transcription factor regulating
the differential expression of lactoferrin gene in pigs and
mice (Wang et al., 1998; Liu and Teng, 1991). Furthermore,
the new AP2 falls into the CpG island of the gene promoter.
Such region is known to facilitate a rapid response to
microbial infection by inducing the production of IL-6 in
milk, prompting the release of the TNF-a, reducing E. coli
counts inmilk (Zhu et al., 2007). The insertion of a cytosine
and the creation of an additional motif for the AP2 in such
CpG region could enhance the protein production and its
correlated effects. An example of how an AP2 can enhance
the transcription is shown in bovine lactating mammary
gland, where the different binding afﬁnity of the AP2 to the
gene promoter of another whey-protein (b-lactoglobulin)
brings to the creation of a more or less efﬁcient
transcriptional complex, which is responsible for differ-
ences in gene expression, even associated with total milk
protein content (Kuss et al., 2003). Thus, as observed for
such whey-protein, it would be reasonable to think that
the presence of an additional AP2 binding site for the goat
lactoferrin could increase the transcriptional activity and
be associated to quantitative differences in gene expres-
sion. This could enhance all the activities related to such
protein and improve mammary gland defence against
bacterial infections.Acknowledgements
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